Trial intelligence / Profile preview

Ticagrelor vs Prasugrel in Clopidogrel Low Responders After PCI

NCT01456364Phase 4Unknown

Sponsor
Deutsches Herzzentrum München
Start
Sep 2011
Primary completion
Apr 2014
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of ticagrelor, prasugrel in coronary heart disease (CHD), sponsored by Deutsches Herzzentrum München. Status: unknown.

02

Drugs

ticagrelorprasugrel
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT01456364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01456364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call